Management of acute ischemic stroke. What is the role of tPA and antithrombotic agents?

Postgraduate Medicine

Volumn 107, Issue 6, 2000, Pages

  Meschia, James F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISABILITY; PROTHROMBIN TIME; QUALITY OF LIFE; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0343962196     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.5.15.1091     Document Type: Conference Paper

References (26)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333(24):1581-7
2. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999;340(23):1781-7
3. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352(9136):1245-51
4. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. Stroke 1994;25(11):2220-6
5. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke - summary statement. Neurology 1996;47(3):835-9
6. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment for Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283(9): 1145-50
7. Brott T, Lu M, Kathari R, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998;29(8):1504-9
8. National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke: experience at eight centers and implications for community practice and patient care. Stroke 1997;28(8):1530-40
9. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study. JAMA 1999;282(21):2003-11
10. Gonner F, Remonda L, Mattle H, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998;29(9):1894-900
11. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 1997;349(9065):1 569-81
12. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997; 349(9066):1641-9
13. Dippel DW. The results of CAPRIE, 1ST and CAST. Thromb Res 1998;92(1 Suppl 1):S13-6
14. Adams HP Jr, Bendixen BH, Leira E, et al. Antithrombotic treatment of ischemic stroke among patients with occlusion of severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53(l):122-5
15. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342(8882): 1255-62
16. Lip GY, Beevers DG. Interpretation of IST and CAST stroke trials. (Letter) Lancet 1997;350(9075):442-3
17. Alberts MJ. tPA in acute ischemic stroke: United States experience and issues for the future. Neurology 1998;51(3 Suppl 3):S53-5
18. DePippo KL, Holas MA, Reding MJ. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol 1992; 49(12): 1259-61
19. Turpie AG. Prophylaxis of venous thromboembolism in stroke patients. Semin Thromb Hemost 1997;23(2):155-7
20. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2(7872):81-4
21. Carter BS, Ogilvy CS, Candia GJ, et al. One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery 1997;40(6):1168-76
22. Kwakkel G, Wagenaar RC, Koelman TW, et al. Effects of intensity of rehabilitation after stroke: a research synthesis. Stroke 1997;28(8):1550-6
23. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 1997;314(7088):1151-9
24. Stroke Unit Trialists' Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke 1997;28(11):2139-44
25. Alberts MJ, Chaturvedi S, Graham G, et al. Acute stroke teams: results of a national survey. Stroke 1998;29(11):2318-20
26. Hachinski V. Thrombolysis in acute stroke. Arch Neurol 1996; 53(12):1308